8-K
filed April 27, 2023, 7:59 PM ET
ticker LXRX
CIK 0001062822
other material
confidence high
sentiment neutral
materiality 0.50
Lexicon shareholders approve amendment to increase equity plan shares to 55M
LEXICON PHARMACEUTICALS, INC.
- Stockholders approved amendment to 2017 Equity Incentive Plan, increasing authorized shares from 30,000,000 to 55,000,000.
- Amendment to 2017 Non-Employee Directors' Equity Incentive Plan increased share reserve from 1,200,000 to 2,000,000.
- Voting results: For: 110,232,367; Against: 24,746,403; Abstain: 16,261,356; Broker non-votes: 13,664,122.
- Amendments adopted by Board on Feb 9, 2023 and approved at annual meeting on April 27, 2023.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
LEXICON PHARMACEUTICALS, INC. shareholders approved Advisory vote to determine the frequency of future advisory votes on the compensation paid to our named executive officers at the 2023-04-27 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-04-27
Exact text from the filing
Advisory vote to determine the frequency of future advisory votes on the compensation paid to our named executive officers 133,664,598 143,970 949,241 16,482,317
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
LEXICON PHARMACEUTICALS, INC. shareholders approved Election of Class II Directors at the 2023-04-27 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-04-27
Exact text from the filing
Election of Class II Directors Name of Director For Withheld Broker Non-Votes Samuel L. Barker, Ph.D. 142,120,279 9,119,847 13,664,122 Christopher J. Sobecki 143,104,310 8,135,816 13,664,122 Judith L. Swain, M.D. 135,882,215 15,357,911 13,664,122
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
LEXICON PHARMACEUTICALS, INC. shareholders approved Ratification and approval of the amendment to the Company’s 2017 Non-Employee Directors’ Equity Incentive Plan at the 2023-04-27 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-04-27
Exact text from the filing
Ratification and approval of the amendment to the Company’s 2017 Non-Employee Directors’ Equity Incentive Plan 132,867,426 2,097,598 16,275,102 13,664,122
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
LEXICON PHARMACEUTICALS, INC. shareholders approved Advisory vote to approve the compensation paid to the Company’s named executive officers at the 2023-04-27 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-04-27
Exact text from the filing
Advisory vote to approve the compensation paid to the Company’s named executive officers 110,285,867 24,701,050 16,253,209
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
LEXICON PHARMACEUTICALS, INC. shareholders approved Ratification and approval of the amendment to the Company’s 2017 Equity Incentive Plan at the 2023-04-27 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-04-27
Exact text from the filing
Ratification and approval of the amendment to the Company’s 2017 Equity Incentive Plan 110,232,367 24,746,403 16,261,356 13,664,122
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
LEXICON PHARMACEUTICALS, INC. shareholders approved Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2023 at the 2023-04-27 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-04-27
Exact text from the filing
Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2023 146,680,955 725,184 17,498,109
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.